1. Topical doxycycline monohydrate hydrogel 1% targeting proteases/PAR2 pathway is a novel therapeutic for atopic dermatitis. Issue 12 (15th October 2020) Authors: Bohannon, Mary; Liu, Mingjin; Nadeau, Peter; Talton, Judy; Gibson, Daniel; Datta, Susmita; Schultz, Gregory; Talton, James; De Benedetto, Anna Journal: Experimental dermatology Issue: Volume 29:Issue 12(2020) Page Start: 1171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗